We use cookies for a better user experience. Read our Privacy Policy
I Agree
Pharmaceutical Testing and Analytical Services Market
The coronavirus (COVID-19) outbreak has put immense pressure on the life sciences industry to innovate in vaccines and treatments. Hence, the RSSL Group has stepped in to offer analytical support services to pharmaceutical companies. Currently, there is an unprecedented demand for technical support pertaining to raw material and finished product testing. Hence, companies in the pharmaceutical testing and analytical services market are meeting demands pertaining to the development of small-molecule drugs and vaccines.
Apart from drugs, companies in the pharmaceutical testing and analytical services market have joined the race to innovate in disinfectants and medical devices that help in combating coronavirus. There is a growing demand for an agile approach and rapid response in the realm of COVID-19 medical treatments. Companies are establishing multi-disciplinary groups that are working on accelerated deadlines. These groups comprise of specialists that conduct contamination identification.
Request a sample to get extensive insights into the Pharmaceutical Testing and Analytical Services Market
Apart from growth opportunities in North America, companies in the pharmaceutical testing and analytical services market are unlocking business avenues in Australia. As such, the National Measurement Institute (NMI) dictates analytical services for Australian manufacturers. Companies in the Australia pharmaceutical testing and analytical services market are boosting their credibility by complying with the regulations laid down by the NMI. As such, the Australia Government is investing in state-of-the-art laboratories that carry out low-level active ingredients measurement and testing of organic residues in medicines.
Companies are gaining efficacy in specialized testing for product verification validation and medicinal cannabis. They are increasing their services to provide consultation to clients that are facing problems in chemical analysis. There is a demand for professional and impartial measurement services. After the coronavirus outbreak, companies are acquiring proficiency in crisis response testing.
To understand how our report can bring difference to your business strategy, Ask for a brochure
The pharmaceutical testing and analytical services market is projected to reach the value of US$ 10.7 Bn by the end of 2030. This is evident since the U.S. employers spend billions of dollars in pre-employment drug testing. However, it has been discovered that urine and blood testing for cannabis use are ineffective in revealing intoxication. Hence, companies in the pharmaceutical testing and analytical services market are becoming aware about cognitive impairment testing to generate accurate outcomes about cannabis intoxication.
There is a growing demand for pharmaceutical testing and analytical services with regard to biological and chemical substances. Solvias— a specialist in contract services for pharmaceutical, biotech, and medical device companies, is expanding its portfolio in elemental and trace analysis, microbiology, and release testing of innovative products. Companies are building a solid reputation with pharmaceutical companies to conduct analysis of biosimilars, monoclonal antibodies, and therapeutic proteins.
Stuck in a neck-to-neck competition with other brands? Request a custom report on Pharmaceutical Testing and Analytical Services Market
Analyst’s Viewpoint
Companies in the pharmaceutical testing and analytical services market are providing comprehensive analytical support to clients for COVID-19 vaccine excipient and buffer solution testing. The market is estimated to expand at a favorable CAGR of ~11% during the forecast period. However, issues such as recurring manufacturing difficulties and continual process optimization are posing challenges for companies. Thus, service providers should participate in discussions initiated by the FDA, which address concerns regarding new modes of operation. Companies should collaborate with government institutes to conduct industry-led research and build strategic programs for the well-being of public. Moreover, certifications and accreditations help in boosting the service providers’ credibility credentials.
Pharmaceutical Testing and Analytical Services Market: Overview
Pharmaceutical Testing and Analytical Services Market – Segmentation
TMR’s study on the global pharmaceutical testing and analytical services market includes information divided into three segments: service type, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global pharmaceutical testing and analytical services market are discussed in detail.
|
Service Type |
|
|
End User |
|
|
Region |
|
Interested in this report?
Get a FREE sample now!
*Get Sample Report (PDF) sent to your email within minutes
Pharmaceutical testing and analytical services market to reach valuation of US$ 10.7 Bn by 2030
Pharmaceutical testing and analytical services market is projected to expand at a CAGR of ~11% from 2020 to 2030
Pharmaceutical testing and analytical services market is driven by increase in the number of clinical trials and rising prevalence of cancer
North America dominated the global pharmaceutical testing and analytical services market and this trend is anticipated to continue during the forecast period
Key players in the global pharmaceutical testing and analytical services market include Eurofins Scientific, Laboratory Corporation of America Holdings, CHARLES RIVER LABORATORIES INTERNATIONAL, INC., SGS S.A., Intertek Group plc
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Key Industry Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. Global Pharmaceutical Testing and Analytical Services Market Forecast
4.5. Global Pharmaceutical Testing and Analytical Services Market Outlook
5. Market Outlook
5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)
5.2. Clinical Trials Analysis
5.3. Covid-19 Impact Analysis
6. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Service Type
6.1. Introduction
6.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
6.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
6.3.1. Bioanalytical Testing
6.3.1.1. Cell-Based Assays
6.3.1.2. Virology Testing
6.3.1.3. Others
6.3.2. Method Development & Validation
6.3.2.1. Extractables & Leachables Method Development & Validation
6.3.2.2. Stability-indicating Method Validation
6.3.2.3. Process Impurity Method Development & Validation
6.3.2.4. Others
6.3.3. Raw Material Testing
6.3.3.1. Heavy Metal Testing
6.3.3.2. Complete Compendial Testing
6.3.3.3. Others
6.3.4. Stability Testing
6.3.4.1. Drug Substance Stability Testing
6.3.4.2. Formulation Evaluation Stability Testing
6.3.4.3. Others
6.3.5. Microbial Testing
6.3.5.1. Microbial Limit Testing
6.3.5.2. Sterility Testing
6.3.5.3. Endotoxin Testing
6.3.5.4. Others
6.3.6. Others
6.4. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Service Type
7. Global Pharmaceutical Testing and Analytical Services Market Analysis, by End-user
7.1. Introduction
7.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
7.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
7.3.1. Medical Device Companies
7.3.2. Pharmaceutical & Biopharmaceutical Companies
7.3.3. Others
7.4. Global Pharmaceutical Testing and Analytical Services Market Analysis, by End-user
8. Global Pharmaceutical Testing and Analytical Services Market Analysis, by Region
8.1. Global Pharmaceutical Testing and Analytical Services Market Scenario, by Region
8.2. Global Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Region
8.3. Global Pharmaceutical Testing and Analytical Services Market Forecast, by Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East & Africa
9. North America Pharmaceutical Testing and Analytical Services Market Analysis
9.1. North America Pharmaceutical Testing and Analytical Services Market Overview
9.2. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country
9.3. North America Pharmaceutical Testing and Analytical Services Market Forecast, by Country
9.3.1. U.S.
9.3.2. Canada
9.4. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
9.5. North America Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
9.5.1. Bioanalytical Testing
9.5.1.1. Cell-Based Assays
9.5.1.2. Virology Testing
9.5.1.3. Others
9.5.2. Method Development & Validation
9.5.2.1. Extractables & Leachables Method Development & Validation
9.5.2.2. Stability-indicating Method Validation
9.5.2.3. Process Impurity Method Development & Validation
9.5.2.4. Others
9.5.3. Raw Material Testing
9.5.3.1. Heavy Metal Testing
9.5.3.2. Complete Compendial Testing
9.5.3.3. Others
9.5.4. Stability Testing
9.5.4.1. Drug Substance Stability Testing
9.5.4.2. Formulation Evaluation Stability Testing
9.5.4.3. Others
9.5.5. Microbial Testing
9.5.5.1. Microbial Limit Testing
9.5.5.2. Sterility Testing
9.5.5.3. Endotoxin Testing
9.5.5.4. Others
9.5.6. Others
9.6. North America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
9.7. North America Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
9.7.1. Medical Devices Companies
9.7.2. Pharmaceutical & Biopharmaceutical Companies
9.7.3. Others
10. Europe Pharmaceutical Testing and Analytical Services Market Analysis
10.1. Europe Pharmaceutical Testing and Analytical Services Market Overview
10.2. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region
10.3. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
10.5. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
10.5.1. Bioanalytical Testing
10.5.1.1. Cell-Based Assays
10.5.1.2. Virology Testing
10.5.1.3. Others
10.5.2. Method Development & Validation
10.5.2.1. Extractables & Leachables Method Development & Validation
10.5.2.2. Stability-indicating Method Validation
10.5.2.3. Process Impurity Method Development & Validation
10.5.2.4. Others
10.5.3. Raw Material Testing
10.5.3.1. Heavy Metal Testing
10.5.3.2. Complete Compendial Testing
10.5.3.3. Others
10.5.4. Stability Testing
10.5.4.1. Drug Substance Stability Testing
10.5.4.2. Formulation Evaluation Stability Testing
10.5.4.3. Others
10.5.5. Microbial Testing
10.5.5.1. Microbial Limit Testing
10.5.5.2. Sterility Testing
10.5.5.3. Endotoxin Testing
10.5.5.4. Others
10.5.6. Others
10.6. Europe Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
10.7. Europe Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
10.7.1. Medical Devices Companies
10.7.2. Pharmaceutical & Biopharmaceutical Companies
10.7.3. Others
11. Asia Pacific Pharmaceutical Testing and Analytical Services Market Analysis
11.1. Asia Pacific Pharmaceutical Testing and Analytical Services Market Overview
11.2. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.3. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region
11.3.1. Japan
11.3.2. China
11.3.3. India
11.3.4. Australia & New Zealand
11.3.5. Rest of Asia Pacific
11.4. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
11.5. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
11.5.1. Bioanalytical Testing
11.5.1.1. Cell-Based Assays
11.5.1.2. Virology Testing
11.5.1.3. Others
11.5.2. Method Development & Validation
11.5.2.1. Extractables & Leachables Method Development & Validation
11.5.2.2. Stability-indicating Method Validation
11.5.2.3. Process Impurity Method Development & Validation
11.5.2.4. Others
11.5.3. Raw Material Testing
11.5.3.1. Heavy Metal Testing
11.5.3.2. Complete Compendial Testing
11.5.3.3. Others
11.5.4. Stability Testing
11.5.4.1. Drug Substance Stability Testing
11.5.4.2. Formulation Evaluation Stability Testing
11.5.4.3. Others
11.5.5. Microbial Testing
11.5.5.1. Microbial Limit Testing
11.5.5.2. Sterility Testing
11.5.5.3. Endotoxin Testing
11.5.5.4. Others
11.5.6. Others
11.6. Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
11.7. Asia Pacific Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
11.7.1. Medical Devices Companies
11.7.2. Pharmaceutical & Biopharmaceutical Companies
11.7.3. Others
12. Latin America Pharmaceutical Testing and Analytical Services Market Analysis
12.1. Latin America Pharmaceutical Testing and Analytical Services Market Overview
12.2. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region
12.3.1. Brazil
12.3.2. Mexico
12.3.3. Rest of Latin America
12.4. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
12.5. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
12.5.1. Bioanalytical Testing
12.5.1.1. Cell-Based Assays
12.5.1.2. Virology Testing
12.5.1.3. Others
12.5.2. Method Development & Validation
12.5.2.1. Extractables & Leachables Method Development & Validation
12.5.2.2. Stability-indicating Method Validation
12.5.2.3. Process Impurity Method Development & Validation
12.5.2.4. Others
12.5.3. Raw Material Testing
12.5.3.1. Heavy Metal Testing
12.5.3.2. Complete Compendial Testing
12.5.3.3. Others
12.5.4. Stability Testing
12.5.4.1. Drug Substance Stability Testing
12.5.4.2. Formulation Evaluation Stability Testing
12.5.4.3. Others
12.5.5. Microbial Testing
12.5.5.1. Microbial Limit Testing
12.5.5.2. Sterility Testing
12.5.5.3. Endotoxin Testing
12.5.5.4. Others
12.5.6. Others
12.6. Latin America Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
12.7. Latin America Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
12.7.1. Medical Devices Companies
12.7.2. Pharmaceutical & Biopharmaceutical Companies
12.7.3. Others
13. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Analysis
13.1. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Overview
13.2. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by Country/Sub-region
13.3.1. GCC Countries
13.3.2. South Africa
13.3.3. Rest of Middle East & Africa
13.4. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by Service Type
13.5. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by Service Type
13.5.1. Bioanalytical Testing
13.5.1.1. Cell-Based Assays
13.5.1.2. Virology Testing
13.5.1.3. Others
13.5.2. Method Development & Validation
13.5.2.1. Extractables & Leachables Method Development & Validation
13.5.2.2. Stability-indicating Method Validation
13.5.2.3. Process Impurity Method Development & Validation
13.5.2.4. Others
13.5.3. Raw Material Testing
13.5.3.1. Heavy Metal Testing
13.5.3.2. Complete Compendial Testing
13.5.3.3. Others
13.5.4. Stability Testing
13.5.4.1. Drug Substance Stability Testing
13.5.4.2. Formulation Evaluation Stability Testing
13.5.4.3. Others
13.5.5. Microbial Testing
13.5.5.1. Microbial Limit Testing
13.5.5.2. Sterility Testing
13.5.5.3. Endotoxin Testing
13.5.5.4. Others
13.5.6. Others
13.6. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share and Attractiveness Analysis, by End-user
13.7. Middle East & Africa Pharmaceutical Testing and Analytical Services Market Forecast, by End-user
13.7.1. Medical Devices Companies
13.7.2. Pharmaceutical & Biopharmaceutical Companies
13.7.3. Others
14. Competitive Landscape
14.1. Competition Matrix
14.2. Global Pharmaceutical Testing and Analytical Services Market Share Analysis, by Company
14.3. Company Profile
14.3.1. Eurofins Scientific
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Laboratory Corporation of America Holdings
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. SGS S.A
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Intertek Group plc
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. RD Laboratories, Inc
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. WuXi AppTec Co., Ltd.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. DYNALABS LLC (Infinity Laboratories)
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. ARL Bio Pharma
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
List of Tables
Table 01: Epidemiology of COVID-19 Country/Sub-region
Table 02: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 03: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030
Table 04: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030
Table 05: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030
Table 06: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030
Table 07: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030
Table 08: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 09: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 10: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 11: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 12: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030
Table 13: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030
Table 14: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030
Table 15: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030
Table 16: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030
Table 17: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 18: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 19: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 20: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030
Table 21: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030
Table 22: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030
Table 23: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030
Table 24: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030
Table 25: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 26: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030
Table 27: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 28: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030
Table 29: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030
Table 30: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030
Table 31: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030
Table 32: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030
Table 33: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 34: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030
Table 35: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 36: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030
Table 37: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030
Table 38: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030
Table 39: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030
Table 40: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030
Table 41: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 42: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030
Table 43: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Service Type, 2018–2030
Table 44: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Bioanalytical Testing, 2018–2030
Table 45: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Method Development & Validation, 2018–2030
Table 46: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Raw Material Testing, 2018–2030
Table 47: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Stability Testing, 2018–2030
Table 48: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by Microbial Testing, 2018–2030
Table 49: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, by End-user, 2018–2030
List of Figures
Figure 01: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast, 2018–2030
Figure 02: Global Pharmaceutical Testing and Analytical Services Market Value Share, by Service Type (2019)
Figure 03: Global Pharmaceutical Testing and Analytical Services Market Value Share, by End-user (2019
Figure 04: Global Pharmaceutical Testing and Analytical Services Market Value Share, by Region (2019)
Figure 05: Number of Registered Studies, by Location
Figure 06: Number of Registered Studies, by Intervention
Figure 07: Global Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2019 and 2030
Figure 08: Global Pharmaceutical Testing and Analytical Services Market Attractiveness, by Service Type, 2020–2030
Figure 09: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Bioanalytical Testing, 2018–2030
Figure 10: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Method Development & Validation, 2018–2030
Figure 11: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Raw Material Testing, 2018–2030
Figure 12: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Stability Testing, 2018–2030
Figure 13: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Microbial Testing, 2018–2030
Figure 14: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Others, 2018–2030
Figure 15: Global Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2019 and 2030
Figure 16: Global Pharmaceutical Testing and Analytical Services Market Attractiveness, by End-user, 2020–2030
Figure 17: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Medical Device Companies, 2018–2030
Figure 18: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Pharmaceutical & Biopharmaceutical Companies, 2018–2030
Figure 19: Global Pharmaceutical Testing and Analytical Services Market Value (US$ Mn), by Others, 2018–2030
Figure 20: Global Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Region, 2019 and 2030
Figure 21: Global Pharmaceutical Testing and Analytical Services Market Attractiveness Analysis, by Region
Figure 22: North America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 23: North America Pharmaceutical Testing and Analytical Services Market Value Share (%), by Country, 2019 and 2030
Figure 24: North America Pharmaceutical Testing and Analytical Services Market Attractiveness, by Country, 2020–2030
Figure 25: North America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2019 and 2030
Figure 26: North America Pharmaceutical Testing and Analytical Services Market Attractiveness, by Service Type, 2020–2030
Figure 27: North America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2019 and 2030
Figure 28: North America Pharmaceutical Testing and Analytical Services Market Attractiveness, by End-user, 2020–2030
Figure 29: Europe Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 30: Europe Pharmaceutical Testing and Analytical Services Market Value Share (%), by Country, 2019 and 2030
Figure 31: Europe Pharmaceutical Testing and Analytical Services Market Attractiveness, by Country, 2020–2030
Figure 32: Europe Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2019 and 2030
Figure 33: Europe Pharmaceutical Testing and Analytical Services Market Attractiveness, by Service Type, 2020–2030
Figure 34: Europe Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2019 and 2030
Figure 35: Europe Pharmaceutical Testing and Analytical Services Market Attractiveness, by End-user, 2020–2030
Figure 36: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 37: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share (%), by Countries/Sub-region, 2019 and 2030
Figure 38: Asia Pacific Pharmaceutical Testing and Analytical Services Market Attractiveness, by Countries/Sub-region, 2020–2030
Figure 39: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2019 and 2030
Figure 40: Asia Pacific Pharmaceutical Testing and Analytical Services Market Attractiveness, by Service Type, 2020–2030
Figure 41: Asia Pacific Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2019 and 2030
Figure 42: Asia Pacific Pharmaceutical Testing and Analytical Services Market Attractiveness, by End-user, 2020–2030
Figure 43: Latin America Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 44: Latin America Pharmaceutical Testing and Analytical Services Market Value Share (%), by Countries/Sub-region, 2019 and 2030
Figure 45: Latin America Pharmaceutical Testing and Analytical Services Market Attractiveness, by Countries/Sub-region, 2020–2030
Figure 46: Latin America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2019 and 2030
Figure 47: Latin America Pharmaceutical Testing and Analytical Services Market Attractiveness, by Service Type, 2020–2030
Figure 48: Latin America Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2019 and 2030
Figure 49: Latin America Pharmaceutical Testing and Analytical Services Market Attractiveness, by End-user, 2020–2030
Figure 50: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 51: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share (%), by Countries/Sub-region, 2019 and 2030
Figure 52: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Attractiveness, by Countries/Sub-region, 2020–2030
Figure 53: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by Service Type, 2019 and 2030
Figure 54: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Attractiveness, by Service Type, 2020–2030
Figure 55: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Value Share Analysis, by End-user, 2019 and 2030
Figure 56: Middle East & Africa Pharmaceutical Testing and Analytical Services Market Attractiveness, by End-user, 2020–2030
Figure 57: Global Pharmaceutical Testing and Analytical Services Market Share, by Company, 2019
Get a free copy if the report you purchased is updated within 90 days
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
